Ensysce Biosciences financial statements

엔시스 바이오사이언시스NASDAQ:ENSC · Nasdaq · Healthcare · sector #17
$0.4298+2.58%
2026-10-06 close

Ensysce Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $5M. 2024 operating profit was −$7M.

Reported results

Ensysce Biosciences notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q